CRISPR Therapeutics AG Lease Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
CONSENT TO SUBLEASE
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2016
Lease Commencement Date Agreement, dated May 1, 2022, by and between CRISPR Therapeutics AG and 105 W First Street Owner, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2022
Second Amendment to Lease dated April __, 2021, by and between CRISPR Therapeutics, Inc. and 33 NYA OWNER (DE) LLC, as successor in interest to CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
DE
2021
First Amendment to Lease dated December 2, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2021
Lease, dated May 5, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2021
Lease, dated July 24, 2020, by and between the Registrant and 105 W First Street Owner, L.L.C
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
MA
2020
Assignment of Sublease and Sub-Sublease, dated December 13, 2019, between Casebia Therapeutics LLC and CRISPR Therapeutics, Inc
Lease Agreements
CRISPR Therapeutics AG
Biotechnology
2020